{
  "id": 14952100,
  "title": "CHMP Backs Ionis TRYNGOLZA For Severe Hypertriglyceridemia In Europe",
  "url": "https://urgent.news/2026/10/16/chmp-backs-ionis-tryngolza-for-severe-hypertriglyceridemia-in-europe",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-10-16T11:36:52.000Z",
  "source": {
    "name": "Nasdaq Markets",
    "slug": "nasdaq-markets",
    "url": "https://www.nasdaq.com/articles/chmp-backs-ionis-tryngolza-severe-hypertriglyceridemia-europe"
  },
  "original_language": "en",
  "account": null,
  "summary": "(RTTNews) - On Friday, Ionis Pharmaceuticals (IONS) announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has recommended approval of TRYNGOLZA (olezarsen) for adults with severe hypertriglyceridemia (sHTG).",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}